Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Rock Ventures V, L.p. Third

10% Owner at Rapport Therapeutics, Inc. (RAPP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.1M

Reported trades

Filed Stock Type Shares Price Value Since
May 28SEC RAPPRapport Therapeutics, Inc. Sell Plan 18,5726,280,525 held (−0%) $40.05 $744K -31.2%
May 13SEC RAPPRapport Therapeutics, Inc. Sell Plan 133,6186,299,097 held (−2%) $40.24 $5.4M -31.5%
  • Sell

    10% Owner Rock Ventures V, L.p. Third sold $744K of RAPP at $40.05 — pre-scheduled 10b5-1 plan sale.

  • Sell

    10% Owner Rock Ventures V, L.p. Third sold $5.4M of RAPP at $40.24 — pre-scheduled 10b5-1 plan sale.